SCHEMBL19494386

SCHEMBL19494386

NC(=O)c1cc(N(O)SN2CCCCC2)sc1NC(=O)c1cc[nH]n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 2/20 0.39
▸ CHEK1 O14757 3/20 0.37
▸ MAPT P10636 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ RAB9A P51151 3/20 0.31
▸ MAPK10 P53779 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ RPS6KA3 P51812 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ GFER P55789 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494498 0.81 CFTR (0.40) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL19494892 0.77 MMP1 (0.41) CFTRMAPTKDM4EMEN1KMT2A
SCHEMBL19494401 0.77 CFTR (0.46) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL16338262 0.76 CFTR (0.67) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL16246221 0.75 CFTR (0.65) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL19494618 0.74 HDAC3 (0.44) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL19494686 0.74 MAPK8 (0.49) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL19494477 0.73 MAPT (0.35) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL19494695 0.73 MAPK1 (0.41) CFTRCHEK1MAPTKDM4EMEN1
SCHEMBL16337653 0.73 CFTR (0.62) CFTRCHEK1MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback